Device Trial Radar · NCT06000332
Evaluation of POC Pulse-dose Demand Oxygen Delivery for Nocturnal Hypoxemia
Last checked: Nov 19, 2026Latest source record: Jan 5, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
20
Actual
Start
Oct 17, 2023
Primary completion
Dec 21, 2023
Study completion Dec 21, 2023
Sponsor
- Lead sponsor
- Inogen Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Aug 21, 2023
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 40 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The aim of this study is to describe the effect of the Inogen Rove 6 Portable Oxygen Concentrator on peripheral oxygen saturation in adults receiving supplemental oxygen at night and examine whether the device can adequately maintain oxygen saturation during sleep.
Conditions
- Nocturnal Hypoxemia
Interventions
InogenOne Rove 6 Portable Oxygen ConcentratorDevice
overnight use of Portable Oxygen Concentrator, 6 hours minimum
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number/% of subjects that could achieve SpO2 ≥90% for >30% of sleep timeTime frame: 6 hours overnight
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Piedmont Healthcare
Statesville, North Carolina
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.